Clearing Lungs With ENaC Inhibition in Primary Ciliary Dyskinesia

NCT02871778 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

123

Enrollment

INDUSTRY

Sponsor class

Conditions

Primary Ciliary Dyskinesia

Interventions

DRUG: VX-371
DRUG: Hypertonic Saline
DRUG: Placebo (0.17% saline)
DRUG: VX-371 + HS
DRUG: Ivacaftor

Sponsor

Parion Sciences

Collaborators

[object Object]